0001209191-20-064582.txt : 20201218
0001209191-20-064582.hdr.sgml : 20201218
20201218210839
ACCESSION NUMBER: 0001209191-20-064582
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201217
FILED AS OF DATE: 20201218
DATE AS OF CHANGE: 20201218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nash Huw M.
CENTRAL INDEX KEY: 0001780085
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38938
FILM NUMBER: 201402164
MAIL ADDRESS:
STREET 1: C/O STOKE THERAPEUTICS, INC.
STREET 2: 45 WIGGINS AVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Stoke Therapeutics, Inc.
CENTRAL INDEX KEY: 0001623526
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471144582
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 PRESTON COURT
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-430-8200
MAIL ADDRESS:
STREET 1: 3 PRESTON COURT
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ASOthera Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20141028
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-17
0
0001623526
Stoke Therapeutics, Inc.
STOK
0001780085
Nash Huw M.
C/O STOKE THERAPEUTICS, INC.
45 WIGGINS AVENUE
BEDFORD
MA
01730
0
1
0
0
COO & CBO
Common Stock
2020-12-17
4
M
0
41985
0.60
A
41985
D
Common Stock
2020-12-17
4
S
0
41985
60.00
D
0
D
Common Stock
2020-12-18
4
M
0
8015
0.60
A
8015
D
Common Stock
2020-12-18
4
S
0
8015
60.00
D
0
D
Employee Stock Option (Right to Buy)
0.60
2020-12-17
4
M
0
41985
0.00
D
2028-04-02
Common Stock
41985
180386
D
Employee Stock Option (Right to Buy)
0.60
2020-12-18
4
M
0
8015
0.00
D
2028-04-02
Common Stock
8015
172371
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The option vested as to 1/48th of the total shares on February 28, 2018, and then 1/48th of the total shares vest at the end of each month thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
/s/ Stephen Tulipano, Attorney-in-Fact
2020-12-18